Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load
Condition: Systemic Amyloidosis Intervention: Drug: Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01) Sponsor: University of Tennessee Graduate School of Medicine Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Condition: Systemic Amyloidosis Interventions: Drug: 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.; Drug: 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m. Sponsors: University of Tennessee Graduate School of Medicine; Attralus, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials
